IP Library Granted Patent US 8,137,929
Granted Patent B2
US 8,137,929 · App. 11/911,563 · Granted Mar 20, 2012

Basic protein purification tags from thermophilic bacteria

Assignee: Novo Nordisk Health Care AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,137,929
App. No.
11/911,563
Granted
Mar 20, 2012
Kind
B2
Abstract

The invention is related to a method for purification of recombinant proteins using highly basic proteins from thermophilic bacteria as purification tags for use in a cation-exchange chromatography purification step. The basic proteins may be ribosomal proteins. The recombinant proteins are expressed in eukaryotic or prokaryotic host cells. The purification tag will typically have a pl above about 9 and comprise from about 15 to about 250 amino acid residues.

Claims (16)

1. A method for purification of a recombinant target protein expressed in a eukaryotic or prokaryotic host cell comprising:

(a) isolating an expressed tagged protein from the host cell, wherein the expressed tagged protein comprises a target protein, the purification tag of SEQ ID NO: 24, and a linker sequence comprising a cleavage site for in vitro cleavage of the target protein from the purification tag;

(b) subjecting the expressed tagged protein to cation-exchange chromatography purification;

(c) cleaving the target protein from the purification tag; and

(d) isolating the target protein.

2. The method according to claim 1 , wherein the linker has from 1 to about 30 amino acid residues.

3. The method according to claim 1 , wherein the linker has from 1 to about 15 amino acid residues.

4. The method according to claim 1 , wherein the linker comprises amino acid residues selected from the group consisting of Pro, Leu and Ala.

5. The method according to claim 1 , wherein the linker comprises a cleavage site which is selected from the group consisting of an enterokinase cleavage site, a Factor Xa cleavage site, a thrombin cleavage site, a Tobacco etcs virus protease cleavage site and a HRV14 3C protease cleavage site.

6. The method according to claim 1 , wherein the linker has a peptide sequence of SEQ ID NO: 9.

7. The method according to claim 1 , wherein the host cell is selected from bacteria or fungi such as Eschericia sp., Bacillus sp., Saccharomyces sp. and, Aspergillus sp.

8. The method according to claim 1 further comprising a heat precipitation step for precipitating thermolabile host cell contaminants before the cation-exchange column in step (b).

9. The method according to claim 1 , wherein the target protein is human hGH or an analogue thereof.

10. The method according to claim 9 , wherein the target protein is hGH-Leu-Ala or Ser-hGH.

11. The method according to claim 8 , wherein from about 30 to about 200 mM NaCl is added before the heat precipitation step.

12. The method of claim 1 wherein cleaving the target protein from the purification tag is accomplished by a suitable processing enzyme.

Assignments (3)
CHANGE OF ADDRESS Recorded Jun 19, 2013
From: NOVO NORDISK HEALTHCARE A/G
To: NOVO NORDISK HEALTHCARE AG
Reel/Frame 030653/0189 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2011
From: NOVO NORDISK A/S
To: NOVO NORDISK HEALTHCARE AG
Reel/Frame 026713/0946 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2008
From: SHAW, ALLAN CHRISTIAN; BANG, SUSANNE; SU, JING
To: NOVO NORDISK A/S
Reel/Frame 021476/0503 →
Priority Claims (1)
DK 2005 00549 · Apr 15, 2005 · national
Continuity (2)
Provisional Application 60675054 · Apr 26, 2005
Related Publication 20090306352A1 · Dec 10, 2009